NVO
Novo Nordisk A/S (NVO) Stock Valuation
Review Novo Nordisk A/S (NVO) valuation with server-rendered company data, supporting context and links to related investor research.
- Price to earnings
- 11.48
- Price to book
- 7.44
- Dividend yield
- 0%
- Return on equity
- 0%
- BTI fair market cap
- $258.22B
- Premium or discount
- 414.16%
- Market cap
- $1.33T
Novo Nordisk A/S (NVO) Stock Valuation research
The Novo Nordisk A/S valuation page presents the available multiples, profitability measures and BTI fair-value context for NVO. Valuation should be compared with the company's growth, margins, balance sheet and relevant peers rather than judged by one multiple.
A premium may reflect stronger expected growth or quality, while a discount can reflect risk or weak expectations. Neither condition alone establishes that a stock is attractive or unattractive.